Brief: Regeneron Pharmaceuticals says declined to submit new bid on 23andMe exceeding original $256 mln
16/06/2025 21:47
June 16 (Reuters) - 23andMe Holding Co MEHCQ.PK: REGENERON PHARMACEUTICALS ON 23ANDME BID SAYS DECLINED TO SUBMIT A NEW BID EXCEEDING ORIGINAL WINNING BID OF $256 MILLION Source text: [ID:] Further company coverage: MEHCQ.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chrome Holding Co
See all newsBrief: Chrome Holding Co Enters Into Stock Purchase Agreement With Bambu Ventures
23andMe seeks approval of larger, $50 million data breach settlement
Brief: 23andMe Holding Co Changes Name to Chrome Holding Co
Brief: 23andMe Holding Says Debtors Repay All Outstanding Indebtedness, Terminate Loan Agreement
founder